Search

L’exercice de la pharmacie fait face aux nombreux enjeux de sécurité sanitaire qui exposent la population aux dangers dus à l’usage irrationnel des médicaments et à des trafics liés à ces derniers. Le secteur pharmaceutique est un des secteurs stratégiques dans la vie humaine requérant une sécurisation avérée en termes de règlementation. La présente étude a pour point de départ, la recrudescence de toutes ces pratiques pharmaceutiques illégales observées dans les officines pharmaceutiques en RDC. À ce propos, l’Arrêté ministériel portant fonctionnement des établissements pharmaceutiques signé en 2015, n’a toujours pas été appliqué comme il se devrait. Aussi, l’objectif que s’assigne cette étude est-il d’analyser cet Arrêté en essayant de comprendre dans quelle mesure sont appliquées les dispositions qui y sont stipulées, et de scruter les raisons liées à l’inapplicabilité de ces différentes dispositions.

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Résumé L’objet de ce travail a porté sur les connaissances, les attitudes et les pratiques des pharmaciens dans l’utilisation du tableau de bord dans la gestion des stocks dans les officines de pharmacie. Il s’agissait d’une étude descriptive et transversale qui s’est déroulée de mars 2022 mars 2023 dans 60 Officines privées du district de Bamako. L’étude était portée sur les pharmaciens titulaires et assistants. La population fut interrogée à l’aide de questionnaire fiches d’enquêtes. L’analyse des données a été faite avec le logiciel SPSS.20, le traitement de texte et la saisie sur Microsoft Word. Les résultats de notre étude ont montré que le sexe masculin était le plus représenté, l’inventaire était la méthode de gestion la plus représentée. La majorité de la population n’utilisaient pas le tableau de bord dans la gestion de stock de médicaments. Après cette étude nous pouvons dire que le tableau de bord est un outil essentiel dans la gestion de stock de médicaments en Officine.

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Les jeunes préparateurs qui sortent de leur centre de formation munis de leur diplôme s'orientent en grande majorité vers l'officine. La motivation et le goût du défi peuvent les guider par la suite vers des carrières plus atypiques. The vast majority of young pharmacy assistants who leave their training center with their diploma are directed towards the pharmacy. Motivation and a taste for challenge may later guide them towards more atypical careers. [ABSTRACT FROM AUTHOR]

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Pour être plus efficient, le système de soins doit dépasser le travail en silo. L'émergence des maisons ou pôles de santé et des communautés professionnelles territoriales de santé favorise un fonctionnement basé sur la synergie, où chaque acteur apporte ses compétences. La réussite tient en la capacité à mettre en œuvre un projet au bénéfice des patients. To be more efficient, the healthcare system must move beyond working in silos. The emergence of health centers or clusters and territorial professional health communities favors an approach based on synergy, where each player contributes his or her skills. Success lies in the ability to implement a project for the benefit of patients. [ABSTRACT FROM AUTHOR]

Objective: To evaluate the development of pharmaceutical interviews in pharmacies in France, in order to understand the organization implemented, any limitations and the expansion of eligible pathologies., Method: A dematerialized questionnaire was designed and distributed between November 2022 and February 2023 to pharmacists and pharmacy students in France (mainland and overseas) via a link to a Google Form., Results: Ninety-four pharmacists from 8 different regions of France responded to the survey. The 94 responses showed that 56% of pharmacists practiced pharmaceutical interviews. Among pharmacists who practiced interviews, pharmacy owners practiced significantly more interviews than other statuses within the pharmacy (67% vs. 38% P=0.014). No other factor, such as dispensary size or geographical area of practice, had a significant impact on whether or not pharmaceutical interviews were carried out. These talks are often carried out at the patient's request, and 89% of them are accompanied by documents for the patient's attention. For pharmacists who do not carry out interviews, time, staffing and remuneration are the 3 main blocking factors found in both quantitative and verbatim variables. Whether or not pharmacists carry out pharmaceutical interviews, this activity received 87% approval from the 94 respondents, and 84% of them would like to include more chronic disease themes., Conclusion: The survey shows that pharmacists approve of the pharmaceutical interviewing activity, but it also highlights obvious logistical obstacles linked to a lack of resources. Thus, even among pharmacists who carry out pharmaceutical interviews, this activity is still carried out relatively infrequently on a routine basis, and often by the incumbent pharmacist, who takes on the responsibility of carrying out this activity., (Copyright © 2024 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Actualités Pharmaceutiques is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

L'équipe officinale est souvent interpellée par des patients dont le bilan biologique rend compte d'une altération de la fonction rénale. Si le vieillissement est le plus souvent en cause, cette dégradation peut également concerner des sujets de tout âge, atteints de pathologies spécifiques. Une insuffisance rénale mal prise en charge peut évoluer jusqu'au stade terminal et rendre nécessaire une dialyse, voire une transplantation. The pharmacy team is often called upon by patients whose biological tests show an alteration in their renal function. Although ageing is most often the cause, this deterioration can also affect patients of any age, suffering from specific pathologies. Poorly managed renal failure can progress to the end stage and make dialysis or even a transplant necessary. [ABSTRACT FROM AUTHOR]

Même si le tabagisme, facteur de risque cardio-vasculaire, est en constante diminution en France, les taux de consommation restent élevés. La prévention et l'accès au sevrage doivent être renforcés, d'autant que la cigarette électronique bouleverse la gestion de la dépendance tabagique. La pharmacie d'officine possède des atouts, dont la proximité et l'accessibilité, pour participer à la lutte antitabac. Des programmes d'accompagnement au sevrage peuvent y être développés. Even if smoking, a cardiovascular risk factor, is constantly decreasing in France, consumption rates remain high. Prevention and access to cessation must be strengthened, especially since the electronic cigarette is revolutionizing the management of tobacco addiction. The pharmacy has a number of assets, including proximity and accessibility, to participate in the fight against tobacco. Support programs for cessation can be developed there. [ABSTRACT FROM AUTHOR]

Les infections sexuellement transmissibles, qui sont provoquées par des agents infectieux, sont particulièrement contagieuses et peuvent être très graves, notamment quand elles ne sont pas curables. Elles représentent un enjeu majeur de santé publique. L'équipe officinale joue un rôle primordial dans leur prévention et dans l'accompagnement des patients. Sexually transmitted infections, which are caused by infectious agents, are particularly contagious and can be very serious, especially when they are not curable. They represent a major public health issue. The pharmacy team plays an essential role in their prevention and in supporting patients. [ABSTRACT FROM AUTHOR]

Depuis plusieurs décennies, les missions du pharmacien canadien ont évolué grâce à la reconnaissance dont il bénéficie en tant que spécialiste de la pharmacothérapie et des médicaments. Le Canada est un État fédéral composé de dix provinces et de trois territoires. Chaque province a toute autorité dans le domaine de la santé et organise la pratique de la pharmacie d'un point de vue législatif et réglementaire. Au Québec, les dix dernières années ont été porteuses d'avancées notables à l'officine. For several decades, the missions of the Canadian pharmacist have evolved thanks to the recognition he enjoys as a specialist in pharmacotherapy and drug. Canada is a federal state composed of ten provinces and three territories. Each province has full authority over health care and organises the practice of pharmacy from a legislative and regulatory perspective. In Quebec, the last ten years have seen significant advances in pharmacy practice. [ABSTRACT FROM AUTHOR]

La télésanté en pharmacie concerne deux formes de prise en charge des patients à distance par vidéotransmission, la téléconsultation et certains actes de télésoin, autorisés durant l'état d'urgence sanitaire. Pour proposer ces services, les pharmaciens d'officine doivent respecter des obligations juridiques et déontologiques liées à l'utilisation des nouvelles technologies de l'information et de la communication. Telehealth in pharmacy concerns two forms of remote patient management by videotransmission, teleconsultation and certain telecare procedures, authorized during the state of health emergency. To offer these services, dispensing pharmacists must comply with legal and ethical obligations related to the use of new information and communication technologies. [ABSTRACT FROM AUTHOR]

Depuis 2009, le métier de pharmacien d'officine s'est enrichi de nombreuses nouvelles missions. Parallèlement, la télémédecine s'est déployée et représente aujourd'hui une étape importante pour la profession. La téléconsultation permet à l'officine d'être identifiée par la population comme une structure ressource de proximité de mise en relation avec un médecin. Avec le développement du télésoin, le pharmacien pourrait être sollicité pour une téléexpertise médicamenteuse et intégré dans une équipe de soins primaires dans le cadre de la télésurveillance des malades chroniques. Since 2009, the job of the dispensing pharmacist has been enriched with many new missions. At the same time, telemedicine has been deployed and now represents an important step for the profession. Teleconsultation allows the pharmacy to be identified by the population as a local resource structure that puts them in contact with a doctor. With the development of telecare, the pharmacist could be solicited for tele-expertise in medicine and integrated into a primary care team for the remote monitoring of chronic patients. [ABSTRACT FROM AUTHOR]

Les soins primaires sont définis par l'Organisation mondiale de la santé comme le premier niveau de contact entre la population et le système de santé. Les contours du conseil officinal de premier recours doivent être arrêtés pour mieux appréhender ce qu'il recouvre, comprendre sa déclinaison pratique et anticiper son évolution au regard des nouvelles missions des pharmaciens. Primary care is defined by the World Health Organization as the first level of contact between the population and the health system. The contours of primary care pharmacy advice need to be defined in order to better understand what it covers, its practical application and anticipate its evolution in relation to the new missions of pharmacists. [ABSTRACT FROM AUTHOR]

Bien que l'officine soit la spécialité la plus connue de la filière pharmaceutique, les missions du pharmacien de ville restent floues aux yeux du grand public. La profession est en constante évolution et s'ancre au centre du système de santé français, ce qui éloignent ses représentants de l'image de "vendeurs de boîtes". Although the pharmacy is the best known speciality of the profession, the tasks of the dispensing pharmacist remain unclear to the general public. Far from the image of the formerly decried "box salesman", the profession is constantly evolving and is anchored after the many developments of recent years, at the center of the French health system. [ABSTRACT FROM AUTHOR]

Les porteurs d'une poche de recueil sont des patients fragiles et cela pour au moins deux raisons. Ils souffrent souvent d'une pathologie grave, ce qui est déjà particulièrement angoissant et déstabilisant, et ont subi une intervention chirurgicale, la stomie, susceptible de transformer leur rapport avec leur corps et son intégrité. Patients with a collection bag are fragile patients for at least two reasons. They often suffer from a serious pathology, which is already particularly distressing and destabilizing, and they have undergone a surgical procedure, the stoma, which is likely to transform their relationship with their body and its integrity. [ABSTRACT FROM AUTHOR]

Une lutte préventive et combative sans précédent est engagée contre les violences quotidiennes par les pouvoirs publics. Pour s'impliquer dans le repérage des situations à risque et l'accueil des victimes, il importe de comprendre les mécanismes en jeu. An unprecedented preventive and combative struggle against daily violence is being waged by the public authorities. In order to become involved in identifying risk situations and welcoming victims, it is important to understand the relevant mechanisms. [ABSTRACT FROM AUTHOR]

La pharmacie française a fait face à une situation inédite, celle de l'épidémie de Covid-19, qui l'a obligée à adapter son fonctionnement pour assurer, dans les meilleures conditions de sécurité, la continuité de l'offre de soins dans les territoires. L'avenir est incertain, mais de profonds changements vont durablement s'imposer dans notre activité. Il faudra panser les stigmates de cette crise, tout en étant partie prenante d'une refonte sociétale que nous pouvons appeler de nos vœux. The French pharmacy was faced with an unprecedented situation, the COVID-19 epidemic, which forced it to adapt its operations to ensure, under the best possible safety conditions, the continuity of healthcare provision in the territories. The future is uncertain, but profound changes in our activity will be necessary in the long term. We will have to heal the scars of this crisis, while at the same time taking part in a societal overhaul that we can call for. [ABSTRACT FROM AUTHOR]

Le congrès de l' European Society for Medical Oncology 2019 a tenu toutes ses promesses. Individualisation des doses des anticancéreux, impact de l'immunothérapie sur les protocoles de prise en charge et bénéfice des biosimilaires pour contrebalancer l'expansion des dépenses, du côté des traitements, les évolutions sont rapides. The European Society for Medical Oncology 2019 congress has lived up to all its promises. Dose individualization of anti-cancer drugs, the impact of immunotherapy on treatment protocols and the benefit of biosimilars to offset the increase of expenses; therapies are rapidly evolving. [ABSTRACT FROM AUTHOR]